Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 70

1.

NextGen advises "Trying to Manage".

Steinhauff D, Ellwanger JH, Lewinska M, Sanganyado E, Ji Y, Karawdeniya BI, Bochatay N, Moore EB, Coulibaly A, Ibrahim S, Jansen DS, James JI, Cole DM, Lipkin A, Adamowicz BM, Cohen CM, Fatehi S, Holmstrom MH, Li R.

Science. 2019 Oct 4;366(6461):28-30. doi: 10.1126/science.aaz5828. No abstract available.

PMID:
31604289
2.

Ladderane phospholipids form a densely packed membrane with normal hydrazine and anomalously low proton/hydroxide permeability.

Moss FR 3rd, Shuken SR, Mercer JAM, Cohen CM, Weiss TM, Boxer SG, Burns NZ.

Proc Natl Acad Sci U S A. 2018 Sep 11;115(37):9098-9103. doi: 10.1073/pnas.1810706115. Epub 2018 Aug 27.

3.

Chemical Synthesis and Self-Assembly of a Ladderane Phospholipid.

Mercer JA, Cohen CM, Shuken SR, Wagner AM, Smith MW, Moss FR 3rd, Smith MD, Vahala R, Gonzalez-Martinez A, Boxer SG, Burns NZ.

J Am Chem Soc. 2016 Dec 14;138(49):15845-15848. Epub 2016 Nov 29.

4.

Enantioselective Dirhodium(II)-Catalyzed Cyclopropanations with Trimethylsilylethyl and Trichloroethyl Aryldiazoacetates.

Negretti S, Cohen CM, Chang JJ, Guptill DM, Davies HML.

Tetrahedron. 2015 Sep 30;71(39):7415-7420. doi: 10.1016/j.tet.2015.05.045. Epub 2015 Jun 2.

5.

Rhodium(II)-catalyzed stereoselective synthesis of allylsilanes.

Guptill DM, Cohen CM, Davies HM.

Org Lett. 2013 Dec 20;15(24):6120-3. doi: 10.1021/ol4028978. Epub 2013 Nov 27.

PMID:
24283585
6.

A path to improved pharmaceutical productivity.

Cohen CM.

Nat Rev Drug Discov. 2003 Sep;2(9):751-3. doi: 10.1038/nrd1180. Review.

PMID:
12951582
7.

Mild spherocytosis and altered red cell ion transport in protein 4. 2-null mice.

Peters LL, Jindel HK, Gwynn B, Korsgren C, John KM, Lux SE, Mohandas N, Cohen CM, Cho MR, Golan DE, Brugnara C.

J Clin Invest. 1999 Jun;103(11):1527-37.

8.

Developmental biology's impact on drug development.

Cohen CM, Platika D, Scangos G, Kilian P.

Nat Biotechnol. 1998 Jul;16(7):628-31. No abstract available.

PMID:
9661194
9.

Questions from a scientific audience: how do I get started?

Cohen CM, Leheny R, Platika D.

Nat Biotechnol. 1998 Jun;16(6):522-4. No abstract available.

PMID:
9624680
11.

The gene encoding protein 4.2 is distinct from the mouse platelet storage pool deficiency mutation pallid.

Gwynn B, Korsgren C, Cohen CM, Ciciotte SL, Peters LL.

Genomics. 1997 Jun 15;42(3):532-5.

PMID:
9205130
12.

Role of N-myristylation in targeting of band 4.2 (pallidin) in nonerythroid cells.

Risinger MA, Korsgren C, Cohen CM.

Exp Cell Res. 1996 Dec 15;229(2):421-31.

PMID:
8986625
13.

Specific loss of protein kinase activities in senescent erythrocytes.

Jindal HK, Ai Z, Gascard P, Horton C, Cohen CM.

Blood. 1996 Aug 15;88(4):1479-87.

PMID:
8695869
14.

Human erythrocyte dematin and protein 4.2 (pallidin) are ATP binding proteins.

Azim AC, Marfatia SM, Korsgren C, Dotimas E, Cohen CM, Chishti AH.

Biochemistry. 1996 Mar 5;35(9):3001-6.

PMID:
8608138
15.

Control of band 3 lateral and rotational mobility by band 4.2 in intact erythrocytes: release of band 3 oligomers from low-affinity binding sites.

Golan DE, Corbett JD, Korsgren C, Thatte HS, Hayette S, Yawata Y, Cohen CM.

Biophys J. 1996 Mar;70(3):1534-42.

16.

Phosphatidylinositol 3-kinase activity in murine erythroleukemia cells during DMSO-induced differentiation.

Ai Z, Misra S, Susa M, Varticovski L, Cohen CM.

Exp Cell Res. 1995 Aug;219(2):454-60.

PMID:
7641797
17.

A point mutation in the protein 4.2 gene (allele 4.2 Tozeur) associated with hereditary haemolytic anaemia.

Hayette S, Morle L, Bozon M, Ghanem A, Risinger M, Korsgren C, Tanner MJ, Fattoum S, Cohen CM, Delaunay J.

Br J Haematol. 1995 Apr;89(4):762-70.

PMID:
7772513
18.

Evidence for the association of protein 4.1 immunoreactive forms with neurofibrillary tangles in Alzheimer's disease brains.

Sihag RK, Wang LW, Cataldo AM, Hamlin M, Cohen CM, Nixon RA.

Brain Res. 1994 Sep 5;656(1):14-26.

PMID:
7804827
22.

Structural domain mapping and phosphorylation of human erythrocyte pallidin (band 4.2).

Dotimas E, Speicher DW, GuptaRoy B, Cohen CM.

Biochim Biophys Acta. 1993 May 14;1148(1):19-29.

PMID:
8499466
23.

Human erythrocyte membrane protein band 4.2 (pallidin).

Cohen CM, Dotimas E, Korsgren C.

Semin Hematol. 1993 Apr;30(2):119-37. Review. No abstract available.

PMID:
8480187
24.

The role of inositol phospholipids in the association of band 4.1 with the human erythrocyte membrane.

Gascard P, Pawelczyk T, Lowenstein JM, Cohen CM.

Eur J Biochem. 1993 Feb 1;211(3):671-81.

25.

Regulation and post-translational modification of erythrocyte membrane and membrane-skeletal proteins.

Cohen CM, Gascard P.

Semin Hematol. 1992 Oct;29(4):244-92. Review. No abstract available.

PMID:
1336625
26.

The murine pallid mutation is a platelet storage pool disease associated with the protein 4.2 (pallidin) gene.

White RA, Peters LL, Adkison LR, Korsgren C, Cohen CM, Lux SE.

Nat Genet. 1992 Sep;2(1):80-3.

PMID:
1284644
27.
29.

Human erythrocyte protein 4.2, a high copy number membrane protein, is N-myristylated.

Risinger MA, Dotimas EM, Cohen CM.

J Biol Chem. 1992 Mar 15;267(8):5680-5.

31.

Selective modulation of band 4.1 binding to erythrocyte membranes by protein kinase C.

Danilov YN, Fennell R, Ling E, Cohen CM.

J Biol Chem. 1990 Feb 15;265(5):2556-62.

32.

Complete amino acid sequence and homologies of human erythrocyte membrane protein band 4.2.

Korsgren C, Lawler J, Lambert S, Speicher D, Cohen CM.

Proc Natl Acad Sci U S A. 1990 Jan;87(2):613-7.

34.
35.
36.

Purification of a membrane-derived human erythroid growth factor.

Feldman L, Cohen CM, Riordan MA, Dainiak N.

Proc Natl Acad Sci U S A. 1987 Oct;84(19):6775-9.

37.

Cell type-specific association between two types of spectrin and two types of intermediate filaments.

Langley RC Jr, Cohen CM.

Cell Motil Cytoskeleton. 1987;8(2):165-73.

PMID:
3690687
38.
39.

Cell biology: origins of the cytoskeleton.

Cohen CM.

Nature. 1986 May 1-7;321(6065):18-9. No abstract available.

PMID:
3703007
40.
41.
42.
43.

Association of spectrin with desmin intermediate filaments.

Langley RC Jr, Cohen CM.

J Cell Biochem. 1986;30(2):101-9.

PMID:
2939097
44.

Neutralization of erythroid burst-promoting activity in vitro with antimembrane antibodies.

Dainiak N, Feldman L, Cohen CM.

Blood. 1985 Apr;65(4):877-85.

PMID:
3978232
45.
46.

Regulation of human erythroid proliferation in vitro by leukocyte surface components.

Dainiak N, Cohen CM.

Ann N Y Acad Sci. 1985;459:129-42. No abstract available.

PMID:
3868314
47.
48.
49.

Functional associations of band 4.1 in the erythrocyte membrane skeleton and their role in inherited membrane skeletal abnormalities.

Cohen CM, Langley RC Jr, Foley SF, Korsgren C.

Prog Clin Biol Res. 1984;159:13-29. No abstract available.

PMID:
6473458
50.

The molecular organization of the red cell membrane skeleton.

Cohen CM.

Semin Hematol. 1983 Jul;20(3):141-58. Review. No abstract available.

PMID:
6226100

Supplemental Content

Loading ...
Support Center